SCHEMBL30108034

SCHEMBL30108034

COc1ccc2c(c1)nc(Cc1ccncc1)n2-c1cc(-c2ccco2)nc([S+](C)[O-])n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
POLB P06746 3/20 0.37
HTT P42858 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
THRB P10828 2/20 0.37
HPGD P15428 2/20 0.37
RECQL P46063 2/20 0.37
KMT2A Q03164 2/20 0.37
MET P08581 1/20 0.37
ALOX12 P18054 1/20 0.37
PTPN7 P35236 1/20 0.37
RAB9A P51151 1/20 0.37
BLM P54132 1/20 0.37
MCL1 Q07820 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PDE10A Q9Y233 2/20 0.36
UBE2I P63279 3/20 0.34
CACNA1B Q00975 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108066 0.86 ADORA2A (0.44) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30108062 0.85 MAPT (0.39) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30107964 0.73 ADORA2A (0.46) METADORA2AADORA1ADORA3ADORA2B
SCHEMBL30108043 0.72 ADORA2A (0.41) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30107942 0.72 ADORA2A (0.47) ALDH1A1HTTKDM4EMAPTHPGD
SCHEMBL30108002 0.71 ADORA2A (0.37) ADORA2AADORA1CNR2
SCHEMBL30108063 0.71 KDM4E (0.40) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30107973 0.63 KDM4E (0.46) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30107951 0.63 PTGS1 (0.46) ALDH1A1POLBHTTKDM4EMEN1
SCHEMBL30108045 0.59 ROCK1 (0.60) ALDH1A1POLBHTTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed